100 related articles for article (PubMed ID: 15207753)
21. Crosstalk between extrinsic and intrinsic cell death pathways in pancreatic cancer: synergistic action of estrogen metabolite and ligands of death receptor family.
Basu A; Castle VP; Bouziane M; Bhalla K; Haldar S
Cancer Res; 2006 Apr; 66(8):4309-18. PubMed ID: 16618756
[TBL] [Abstract][Full Text] [Related]
22. Concentration-dependent effects of a selective estrogen receptor modulator raloxifene on proliferation and apoptosis in human uterine leiomyoma cells cultured in vitro.
Liu J; Matsuo H; Xu Q; Chen W; Wang J; Maruo T
Hum Reprod; 2007 May; 22(5):1253-9. PubMed ID: 17220163
[TBL] [Abstract][Full Text] [Related]
23. Treatment with non-hypercalcemic analogs of 1,25-dihydroxyvitamin D3 increases responsiveness to 17beta-estradiol, dihydrotestosterone or raloxifene in primary human osteoblasts.
Katzburg S; Hendel D; Waisman A; Posner GH; Kaye AM; Somjen D
J Steroid Biochem Mol Biol; 2004 Feb; 88(2):213-9. PubMed ID: 15084353
[TBL] [Abstract][Full Text] [Related]
24. Altered expression of membrane-bound and soluble CD95/Fas contributes to the resistance of fibrotic lung fibroblasts to FasL induced apoptosis.
Bühling F; Wille A; Röcken C; Wiesner O; Baier A; Meinecke I; Welte T; Pap T
Respir Res; 2005 Apr; 6(1):37. PubMed ID: 15833141
[TBL] [Abstract][Full Text] [Related]
25. Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts.
Nakamura T; Imai Y; Matsumoto T; Sato S; Takeuchi K; Igarashi K; Harada Y; Azuma Y; Krust A; Yamamoto Y; Nishina H; Takeda S; Takayanagi H; Metzger D; Kanno J; Takaoka K; Martin TJ; Chambon P; Kato S
Cell; 2007 Sep; 130(5):811-23. PubMed ID: 17803905
[TBL] [Abstract][Full Text] [Related]
26. Platycodin D-induced apoptosis through nuclear factor-kappaB activation in immortalized keratinocytes.
Ahn KS; Hahn BS; Kwack K; Lee EB; Kim YS
Eur J Pharmacol; 2006 May; 537(1-3):1-11. PubMed ID: 16631160
[TBL] [Abstract][Full Text] [Related]
27. Morphologic effects of epithelial ion channels on the mouse uterus: differences between raloxifene analog (LY117018) and estradiol treatments.
Nobuzane T; Tashiro S; Kudo Y
Am J Obstet Gynecol; 2008 Oct; 199(4):363.e1-6. PubMed ID: 18456231
[TBL] [Abstract][Full Text] [Related]
28. Effects of 17beta-estradiol on growth and apoptosis in human vascular endothelial cells: influence of mechanical strain and tumor necrosis factor-alpha.
Ling S; Zhou L; Li H; Dai A; Liu JP; Komesaroff PA; Sudhir K
Steroids; 2006 Sep; 71(9):799-808. PubMed ID: 16806337
[TBL] [Abstract][Full Text] [Related]
29. Alteration of activity and survival of osteoblasts obtained from human periodontitis patients: role of TRAIL.
Mori G; Brunetti G; Colucci S; Ciccolella F; Coricciati M; Pignataro P; Oranger A; Ballini A; Farronato D; Mastrangelo F; Tetè S; Grassi FR; Grano M
J Biol Regul Homeost Agents; 2007; 21(3-4):105-14. PubMed ID: 18261262
[TBL] [Abstract][Full Text] [Related]
30. Influence of the selective oestrogen receptor modulator (raloxifene hydrochloride) on IL-6, TNF-alpha, TGF-beta1 and bone turnover markers in the treatment of postmenopausal osteoporosis.
Ozmen B; Kirmaz C; Aydin K; Kafesciler SO; Guclu F; Hekimsoy Z
Eur Cytokine Netw; 2007 Sep; 18(3):148-53. PubMed ID: 17823083
[TBL] [Abstract][Full Text] [Related]
31. Intracellular mechanisms mediating tocotrienol-induced apoptosis in neoplastic mammary epithelial cells.
Sylvester PW; Shah S
Asia Pac J Clin Nutr; 2005; 14(4):366-73. PubMed ID: 16326643
[TBL] [Abstract][Full Text] [Related]
32. Critical roles for JNK, c-Jun, and Fas/FasL-Signaling in vitamin E analog-induced apoptosis in human prostate cancer cells.
Jia L; Yu W; Wang P; Li J; Sanders BG; Kline K
Prostate; 2008 Mar; 68(4):427-41. PubMed ID: 18196534
[TBL] [Abstract][Full Text] [Related]
33. Differential effects of 17beta-estradiol and raloxifene on VSMC phenotype and expression of osteoblast-associated proteins.
Rzewuska-Lech E; Jayachandran M; Fitzpatrick LA; Miller VM
Am J Physiol Endocrinol Metab; 2005 Jul; 289(1):E105-12. PubMed ID: 15713688
[TBL] [Abstract][Full Text] [Related]
34. Apoptosis in raloxifene-treated postmenopausal women.
Biri A; Yurtcu E; Ciftci B; Korucuoğlu U; Ilhan MN; Ergun MA; Gursoy R; Biberoglu K
Cell Biol Int; 2007 Mar; 31(3):289-92. PubMed ID: 17175181
[TBL] [Abstract][Full Text] [Related]
35. Decoy receptor 3 expressed in rheumatoid synovial fibroblasts protects the cells against Fas-induced apoptosis.
Hayashi S; Miura Y; Nishiyama T; Mitani M; Tateishi K; Sakai Y; Hashiramoto A; Kurosaka M; Shiozawa S; Doita M
Arthritis Rheum; 2007 Apr; 56(4):1067-75. PubMed ID: 17393415
[TBL] [Abstract][Full Text] [Related]
36. Rationale for using raloxifene to prevent both osteoporosis and breast cancer in postmenopausal women.
Lee WL; Chao HT; Cheng MH; Wang PH
Maturitas; 2008 Jun; 60(2):92-107. PubMed ID: 18534794
[TBL] [Abstract][Full Text] [Related]
37. Hepatocellular apoptosis is mediated by TNFalpha-dependent Fas/FasLigand cytotoxicity in a murine model of acute liver failure.
Kuhla A; Eipel C; Siebert N; Abshagen K; Menger MD; Vollmar B
Apoptosis; 2008 Dec; 13(12):1427-38. PubMed ID: 18946736
[TBL] [Abstract][Full Text] [Related]
38. Down-regulation of Bcl-2 enhances estrogen apoptotic action in long-term estradiol-depleted ER(+) breast cancer cells.
Song RX; Zhang Z; Mor G; Santen RJ
Apoptosis; 2005 May; 10(3):667-78. PubMed ID: 15909128
[TBL] [Abstract][Full Text] [Related]
39. Gene expression changes accompanying p53 activity during estrogen treatment of osteoblasts.
Chandar N; Logan D; Szajkovics A; Harmston W
Life Sci; 2004 Sep; 75(17):2045-55. PubMed ID: 15312749
[TBL] [Abstract][Full Text] [Related]
40. [Lasofoxifene, a next generation estrogen receptor modulator: preclinical studies].
Maeda T; Ke HZ; Simmons H; Thompson D
Clin Calcium; 2004 Oct; 14(10):85-93. PubMed ID: 15577137
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
